Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum.
Rick J, Gould LJ, Marzano AV, Garg A, Chen D, Oakes DL, Dissemond J, Herfarth H, Friedman MA, Alavi A, Yamamoto T, Gerbens LAA, Thomas KS, Ortega-Loayza AG. Rick J, et al. Among authors: yamamoto t. Arch Dermatol Res. 2023 May;315(4):983-988. doi: 10.1007/s00403-022-02424-1. Epub 2022 Oct 28. Arch Dermatol Res. 2023. PMID: 36305958
A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG; UPGRADE. Jacobson ME, et al. Among authors: yamamoto t. Br J Dermatol. 2024 Feb 16;190(3):392-401. doi: 10.1093/bjd/ljad420. Br J Dermatol. 2024. PMID: 37952167
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Kamal K, et al. Among authors: yamamoto t. J Invest Dermatol. 2024 Jun;144(6):1295-1300.e6. doi: 10.1016/j.jid.2023.12.006. Epub 2023 Dec 16. J Invest Dermatol. 2024. PMID: 38110114
Peristomal pyoderma gangrenosum: Report on 11 cases.
Kikuchi N, Yamamoto T. Kikuchi N, et al. Among authors: yamamoto t. J Dermatol. 2020 Aug;47(8):e282-e283. doi: 10.1111/1346-8138.15396. Epub 2020 May 22. J Dermatol. 2020. PMID: 32441368 No abstract available.
17,365 results
You have reached the last available page of results. Please see the User Guide for more information.